ArticlePharmacoepidemiology and drug safety2022

Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.

Magdalene M Assimon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.